NCX470

Published

dm+d

Unassigned

New Medicines

Open angle glaucoma or intraocular hypertension

Information

New molecular entity
Nicox S.A
Nicox S.A

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Second-generation nitric oxide (NO)-donating prostaglandin analogue. On instillation into the eye both bimatoprost and NO are released, increasing the outflow of aqueous fluid from the eye, thereby reducing the IOP.
The most common form of glaucoma, approximately 1-2% of the population aged over 40 are affected but about half are unaware of it. Prevalence increases with age, affecting about 10% of people aged over 70 [2].
Open angle glaucoma or intraocular hypertension
Topical